🇺🇸 FDA
Patent

US 8247228

Method of inducing memory B cell development and terminal differentiation

granted A61KA61K2035/124A61K35/17

Quick answer

US patent 8247228 (Method of inducing memory B cell development and terminal differentiation) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2035/124, A61K35/17, A61K38/20, A61K40/13